Selection of systemic therapy in patients with locally advanced and recurrent/metastatic head and neck cancer: RAND-based expert opinion by an Italian multidisciplinary panel:

Marco Benasso,Pierluigi Bonomo,Michela Buglione,M.G. Ghi,Lisa Licitra,Stefano Maria Magrini,Marco Merlano,Livio Presutti,Graziana Ronzino,Daris Ferrari

Selection of systemic therapy in patients with locally advanced and recurrent/metastatic head and neck cancer: RAND-based expert opinion by an Italian multidisciplinary panel:

2019

Marco Benasso
Pierluigi Bonomo
Michela Buglione
M.G. Ghi
Lisa Licitra
Stefano Maria Magrini
Marco Merlano
Livio Presutti
Graziana Ronzino
Daris Ferrari

Background:Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous disease often presenting at an already advanced stage. Cisplatin chemoradiotherapy is the standard treatment for locally ...

Keywords:

Internal medicine
Standard treatment
Systemic therapy
Oncology
Head and neck squamous-cell carcinoma
Pathology
Chemoradiotherapy
Chemotherapy
Cisplatin
Medicine
Radiation therapy
Head and neck cancer
Disease

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations